ZALEVSKY JONATHAN (Chief R&D Officer) received a stock award from NEKTAR THERAPEUTICS
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/23/2025ACC: 0001193125-25-331189
Officer· Chief R&D Officer
Since Oct 2019
+31.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
31.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
32.9%
12/22/2025
18.97K→25.22K
Total
Net shares
+6.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | A · Award | +6.25K | — | — | 32.9% | 18.97K | 25.22K |
| Total | +6.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
25K shares
Shares
+25K
Strike price
43.48
Held after
25K
Exercisable
—
12/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock25K shares | 12/22/2025 | A · Award | +25K | 43.48 | — | 25K |